Stemcells (NASDAQ: STEM) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $284 thousand versus the consensus estimate of $290 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.

Earnings